Evidence map›Paper›PMID 41249980›Full record

ArticleBMC pregnancy and childbirth2025

The Lioness™ device: a prospective non-randomized safety and feasibility study of a novel device for preterm birth delay and prevention.

Doron Kabiri, Hagai Amsalem, Salem Kees, Keren Ofir, Abraham Tsur, Eyal Schiff, Sarit Atia Shmueli, David Shashar

Abstract readControlled Clinical Trial
In one paragraph

Article in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Doron KabiriDepartment of Obstetrics and Gynecology, Hadassah Medical Organization, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. doronkabiri@gmail.com.
Hagai AmsalemDepartment of Obstetrics and Gynecology, Hadassah Medical Organization, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Salem KeesDepartment of Obstetrics and Gynecology, Chaim Sheba Medical Center, Ramat Gan, Israel.
Keren OfirDepartment of Obstetrics and Gynecology, Chaim Sheba Medical Center, Ramat Gan, Israel.
Abraham TsurDepartment of Obstetrics and Gynecology, Chaim Sheba Medical Center, Ramat Gan, Israel.
Eyal SchiffDepartment of Obstetrics and Gynecology, Chaim Sheba Medical Center, Ramat Gan, Israel.
Sarit Atia ShmueliDepartment of Obstetrics and Gynecology, Chaim Sheba Medical Center, Ramat Gan, Israel.
David ShasharDepartment of Obstetrics and Gynecology, Chaim Sheba Medical Center, Ramat Gan, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPreterm birth is a leading cause of neonatal mortality and morbidity. Existing interventions to reduce preterm birth risk, such as progesterone therapy, cervical cerclage, and the Arabin pessary, demonstrate limited efficacy, particularly in women with twin pregnancies or a history of preterm birth. The Lioness™ is an elastic silicone ring, with six supporting arms and an encompassing band placed around the cervix at the site of the Shirodkar cerclage, promoting cervical elongation and helping to maintain it throughout pregnancy. It aims to reduce the risk of preterm birth by providing mechanical support to the cervix and preventing early cervical shortening. It is designed for non-surgical placement with dedicated application tools, by the physician in the clinic in a few minutes' procedure.

objectiveTo evaluate the functionality of the Lioness™ device among pregnant women at risk of preterm birth, through serial cervical measurements. STUDY

designThis is a secondary analysis of a prospective, non-randomized, open-label, single-arm safety and feasibility study involving participants at risk for preterm birth with either a history of spontaneous preterm birth before the 37th gestational week without cervical insufficiency or a Dichorionic Diamniotic (DCDA) twin pregnancy. The earlier study evaluated Unanticipated Serious Adverse Device Effects (USADE) and patient satisfaction. Given that cervical length is a key predictor of preterm birth, this analysis focused on serial cervical length measurements and safety-related outcomes following Lioness placement. The study was not powered to assess preterm birth incidence.

results11 of 12 participants completed the study and 10 of 11 reached term or a few days before term. The study documented only mild and transient adverse events, primarily related to device placement. Initial cervical length measurements taken prior to device placement averaged 42 mm. Following placement, measurements at 20, 24, and 28 weeks of gestation consistently showed an average increase to 49 mm, 49 mm, and 45 mm, respectively. Duration of pregnancy from Lioness™ device placement averaged 142 days (134 to 155 days).

conclusionsThese results indicate a notable trend in cervical elongation associated with the use of the Lioness™ device, suggesting its potential to enhance cervical support during pregnancy. These preliminary findings suggest that the Lioness

Indexed as

Cerclage, CervicalCervix UteriPremature BirthSurgical InstrumentsAdultCervical Length MeasurementFeasibility StudiesFemaleGestational AgeHumansPatient SatisfactionPregnancyProspective StudiesSecondary Data AnalysisTreatment OutcomeHigh-Risk pregnancyInnovations in obstetricsLioness devicePreterm birth

Identifiers

PMID41249980
PMCPMC12625020

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.